Skip to main content Help with accessibility Skip to main navigation

Melatonin

Indication

For the Treatment of Rapid Eye Movement (REM) Sleep Behaviour Disorder (RBD) in Parkinson’s Disease and Lewy Body Dementia

Amber level 0

Brand:

Circadin®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Central nervous system

Background

Melatonin prolonged release tablets are suitable for prescribing in primary care following recommendation or initiation by a specialist when clonazepam is not considered to be appropriate.
• Little or no specific monitoring required.
• Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care.
• Brief prescribing document or information sheet may be required.

Recommendation

LSCMMG Recommendation:

Amber level 0

Reason for decision:

Suitable for GP prescribing following recommendation/initiation by specialist

Decisions of Lancashire local decision making groups

Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
What do the colours mean?

Last Updated: 12 - Mar - 2020